{"id":"https://openalex.org/W7214957508","doi":"https://doi.org/10.64898/2026.09.29.26364283","title":"Uveitis with teclistamab and elranatamab: infection or inflammation?","display_name":"Uveitis with teclistamab and elranatamab: infection or inflammation?","publication_year":2026,"publication_date":"2026-09-30","ids":{"openalex":"https://openalex.org/W7214957508","doi":"https://doi.org/10.64898/2026.09.29.26364283"},"language":"en","primary_location":{"id":"doi:10.64898/2026.09.29.26364283","doi":"https://doi.org/10.64898/2026.09.29.26364283","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.29.26364283","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/30/2026.09.29.26364283.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/30/2026.09.29.26364283.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009170792","display_name":"Yupeng Wang","orcid":"https://orcid.org/0009-0009-4217-6569","observed_orcids":["https://orcid.org/0009-0009-4217-6569"]},"institutions":[{"id":"https://openalex.org/I99065089","display_name":"Tsinghua University","ror":"https://ror.org/03cve4549","country_code":"CN","type":"education","lineage":["https://openalex.org/I99065089"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yupeng Wang","raw_affiliation_strings":["Tsinghua Medicine, Tsinghua University, Beijing, China"],"raw_orcid":"https://orcid.org/0009-0009-4217-6569","affiliations":[{"raw_affiliation_string":"Tsinghua Medicine, Tsinghua University, Beijing, China","institution_ids":["https://openalex.org/I99065089"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016419607","display_name":"Y.-H. Guo","orcid":"https://orcid.org/0000-0002-5220-9872","observed_orcids":["https://orcid.org/0000-0002-5220-9872"]},"institutions":[{"id":"https://openalex.org/I2799694172","display_name":"Danbury Hospital","ror":"https://ror.org/04t2rv460","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339","https://openalex.org/I2799694172","https://openalex.org/I4405252557"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yuhao Guo","raw_affiliation_strings":["Department of Medicine, Danbury Hospital, Zucker School of Medicine at Hofstra/Northwell, Danbury, CT, USA"],"raw_orcid":"https://orcid.org/0000-0002-5220-9872","affiliations":[{"raw_affiliation_string":"Department of Medicine, Danbury Hospital, Zucker School of Medicine at Hofstra/Northwell, Danbury, CT, USA","institution_ids":["https://openalex.org/I2799694172"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5016419607"],"corresponding_institution_ids":["https://openalex.org/I2799694172"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.8198000192642212,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.8198000192642212,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.07020000368356705,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.06859999895095825,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/uveitis","display_name":"uveitis","score":0.9710000157356262},{"id":"https://openalex.org/keywords/teclistamab","display_name":"teclistamab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/elranatamab","display_name":"elranatamab","score":1.0},{"id":"https://openalex.org/keywords/bcma-cd3-bispecific-antibody","display_name":"BCMA-CD3 bispecific antibody","score":0.8230000138282776},{"id":"https://openalex.org/keywords/b-cell-maturation-antigen","display_name":"BCMA","score":0.7549999952316284},{"id":"https://openalex.org/keywords/opportunistic-infections","display_name":"opportunistic infections","score":0.8389999866485596},{"id":"https://openalex.org/keywords/immune-mediated-inflammation","display_name":"immune-mediated inflammation","score":0.8569999933242798},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.9829999804496765},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4830000102519989},{"id":"https://openalex.org/keywords/t-cell-redirection","display_name":"T cell redirection","score":0.5090000033378601},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.4830000102519989},{"id":"https://openalex.org/keywords/ophthalmological-assessment","display_name":"ophthalmological assessment","score":0.5820000171661377}],"concepts":[{"id":"https://openalex.org/C2776194053","wikidata":"https://www.wikidata.org/wiki/Q280027","display_name":"Uveitis","level":2,"score":0.9359999895095825},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8640000224113464},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5044000148773193},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4708000123500824},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.45249998569488525},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4458000063896179},{"id":"https://openalex.org/C2777732132","wikidata":"https://www.wikidata.org/wiki/Q6946","display_name":"Cytomegalovirus","level":5,"score":0.3546000123023987},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.34209999442100525},{"id":"https://openalex.org/C94624232","wikidata":"https://www.wikidata.org/wiki/Q3150667","display_name":"Indeterminate","level":2,"score":0.3070000112056732},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.30059999227523804},{"id":"https://openalex.org/C45189115","wikidata":"https://www.wikidata.org/wiki/Q502159","display_name":"Serology","level":3,"score":0.3000999987125397},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.28450000286102295},{"id":"https://openalex.org/C2776148792","wikidata":"https://www.wikidata.org/wiki/Q3041498","display_name":"Eye disease","level":2,"score":0.2793999910354614},{"id":"https://openalex.org/C2776713392","wikidata":"https://www.wikidata.org/wiki/Q278859","display_name":"Uvea","level":3,"score":0.2770000100135803},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27649998664855957},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.26980000734329224},{"id":"https://openalex.org/C143095724","wikidata":"https://www.wikidata.org/wiki/Q515895","display_name":"Odds","level":3,"score":0.26930001378059387}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.09.29.26364283","doi":"https://doi.org/10.64898/2026.09.29.26364283","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.29.26364283","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/30/2026.09.29.26364283.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.09.29.26364283","doi":"https://doi.org/10.64898/2026.09.29.26364283","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.29.26364283","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/09/30/2026.09.29.26364283.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214957508.pdf","grobid_xml":"https://content.openalex.org/works/W7214957508.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W2005366883","https://openalex.org/W2064716383","https://openalex.org/W4282033105","https://openalex.org/W4312072518","https://openalex.org/W4322730657","https://openalex.org/W4385839624","https://openalex.org/W4396696202","https://openalex.org/W4411436789","https://openalex.org/W4412488863","https://openalex.org/W4416788643","https://openalex.org/W7143753682"],"related_works":["https://openalex.org/W2064877272","https://openalex.org/W6976931719","https://openalex.org/W2083993812","https://openalex.org/W2951699697","https://openalex.org/W4392390467","https://openalex.org/W2302672524","https://openalex.org/W2142823343","https://openalex.org/W134752052","https://openalex.org/W816732190","https://openalex.org/W2312591674"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"In":[2],"2026,":[3],"the":[4,21,78,214],"US":[5],"Food":[6],"and":[7,31,77,89,130,141,158,167,184,224,247,270],"Drug":[8],"Administration":[9],"(FDA)":[10],"identified":[11],"uveitis":[12,98,160,194,231,239,251],"as":[13,105],"a":[14,69,114,118,196,236,254],"potential":[15],"signal":[16,197,232,255],"of":[17,127,132,213,266,272],"serious":[18],"risk":[19],"for":[20,81,164,168,199,207],"B-cell":[22],"maturation":[23],"antigen":[24],"(BCMA)":[25],"\u00d7":[26],"CD3":[27,90,169],"bispecific":[28,91,170,244],"antibodies":[29,92,171,245],"teclistamab":[30,129,208],"elranatamab.":[32,258],"Uveitis":[33,122],"in":[34,125,191],"this":[35],"setting":[36],"may":[37],"reflect":[38],"opportunistic":[39],"infection":[40],"or":[41,111,209],"immune-mediated":[42,108,193,250],"inflammation,":[43],"which":[44],"require":[45],"opposite":[46],"management.":[47],"Methods":[48],"We":[49],"analyzed":[50],"FDA":[51,230],"Adverse":[52],"Event":[53],"Reporting":[54],"System":[55],"(FAERS)":[56],"reports":[57,65,135],"from":[58,219],"July":[59],"2020":[60],"to":[61,117,234],"June":[62],"2026":[63],"(8,690,601":[64],"after":[66],"deduplication)":[67],"using":[68],"case\u2013non-case":[70],"design,":[71],"calculating":[72],"reporting":[73],"odds":[74],"ratios":[75],"(RORs)":[76],"information":[79],"component":[80],"primary-suspect":[82,97],"reports.":[83],"Comparators":[84],"were":[85,149,176,185],"belantamab":[86],"mafodotin,":[87],"talquetamab":[88],"used":[93,172],"outside":[94,173],"myeloma.":[95,174],"Every":[96],"report":[99],"(n":[100],"=":[101],"76)":[102],"was":[103,123,161,226],"classified":[104],"infectious,":[106],"probable":[107],"(hereafter":[109],"immune-mediated)":[110],"indeterminate":[112],"by":[113,241],"physician":[115,223],"blinded":[116],"rule-based":[119],"algorithm.":[120],"Results":[121],"reported":[124,163],"18":[126],"2,995":[128],"29":[131],"1,691":[133],"elranatamab":[134,200,216],"(ROR":[136],"4.10":[137],"[95%":[138],"CI":[139],"2.58\u20136.52]":[140],"11.85":[142],"[8.21\u201317.12]).":[143],"Of":[144],"these":[145],"47":[146],"cases,":[147],"20":[148],"infectious":[150,238],"(18":[151],"cytomegalovirus":[152,273],"chorioretinitis;":[153],"median":[154],"onset":[155,181],"92":[156],"days),":[157],"infection-specified":[159],"disproportionately":[162],"both":[165],"agents":[166],"Thirteen":[175],"immune-mediated,":[177],"arose":[178],"early":[179,249],"(median":[180],"4":[182],"days)":[183],"co-reported":[186],"with":[187,257],"cytokine":[188],"release":[189],"syndrome":[190],"six;":[192],"showed":[195,253],"only":[198,256],"(8":[201],"cases;":[202],"ROR":[203],"3.59,":[204],"1.79\u20137.18),":[205],"not":[206],"any":[210],"comparator.":[211],"Six":[212],"eight":[215],"cases":[217],"originated":[218],"Japan.":[220],"Agreement":[221],"between":[222],"algorithm":[225],"98.7%.":[227],"Conclusions":[228],"The":[229],"appears":[233],"comprise":[235],"late":[237],"shared":[240],"most":[242],"T-cell\u2013redirecting":[243],"examined":[246],"an":[248],"that":[252],"These":[259],"hypothesis-generating":[260],"findings":[261],"support":[262],"prompt":[263],"ophthalmological":[264],"assessment":[265],"new":[267],"visual":[268],"symptoms":[269],"exclusion":[271],"retinitis":[274],"before":[275],"corticosteroids":[276],"are":[277],"started.":[278]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-10-01T00:00:00"}